Gene · 2887
Papers1,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNAs in Intervertebral Disc Degeneration: An Updated Review. | Front Mol Biosci | 2021 | 35071323 | PubTator, text mining | PubMed |
| Can Time-Lapse Incubation and Monitoring Be Beneficial to Assisted Reproduction Technology Outcomes? A Randomized Controlled Trial Using Day 3 Double Embryo Transfer. | Front Physiol | 2021 | 35058802 | PubTator, text mining | PubMed |
| Genome-wide survey of parent-of-origin-specific associations across clinical traits derived from electronic health records. | HGG Adv | 2021 | 35047837 | PubTator, text mining | PubMed |
| Circulating Placental Alkaline Phosphatase Expressing Exosomes in Maternal Blood Showed Temporal Regulation of Placental Genes. | Front Med (Lausanne) | 2021 | 35004728 | PubTator, text mining | PubMed |
| COVID-19 Transcriptomic Atlas: A Comprehensive Analysis of COVID-19 Related Transcriptomics Datasets. | Front Genet | 2021 | 35003208 | PubTator, text mining | PubMed |
| Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis. | Cells | 2021 | 34943909 | PubTator, text mining | PubMed |
| Editorial: Interplay Between RNA Processing Machinery and Epigenetic Regulation in Gene Expression. | Front Genet | 2021 | 34925469 | PubTator, text mining | PubMed |
| How Compensatory Mechanisms and Adaptive Rewiring Have Shaped Our Understanding of Therapeutic Resistance in Cancer. | Cancer Res | 2021 | 34911779 | PubTator, text mining | PubMed |
| Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules. | Clin Epigenetics | 2021 | 34906185 | PubTator, text mining | PubMed |
| The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses. | Front Cell Dev Biol | 2021 | 34869377 | PubTator, text mining | PubMed |
| MYCN in Neuroblastoma: "Old Wine into New Wineskins". | Diseases | 2021 | 34842635 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms of ART-Related Imprinting Disorders: Lessons From iPSC and Mouse Models. | Genes (Basel) | 2021 | 34828310 | PubTator, text mining | PubMed |
| Tissue and Temperature-Specific RNA-Seq Analysis Reveals Genomic Versatility and Adaptive Potential in Wild Sea Turtle Hatchlings (Caretta caretta). | Animals (Basel) | 2021 | 34827746 | PubTator, text mining | PubMed |
| Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer. | Biology (Basel) | 2021 | 34827136 | PubTator, text mining | PubMed |
| Evolutionary epigenomic analyses in mammalian early embryos reveal species-specific innovations and conserved principles of imprinting. | Sci Adv | 2021 | 34818044 | PubTator, text mining | PubMed |
| Identifying regulators of parental imprinting by CRISPR/Cas9 screening in haploid human embryonic stem cells. | Nat Commun | 2021 | 34795250 | PubTator, text mining | PubMed |
| Narrative review of emerging roles for AKT-mTOR signaling in cancer radioimmunotherapy. | Ann Transl Med | 2021 | 34790802 | PubTator, text mining | PubMed |
| DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment? | Int J Mol Sci | 2021 | 34769081 | PubTator, text mining | PubMed |
| Integrative Bioinformatics approaches to therapeutic gene target selection in various cancers for Nitroglycerin. | Sci Rep | 2021 | 34764329 | PubTator, text mining | PubMed |
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2887/papers?page=16